Skip to content
Recovery & Performance PeptidesRecovery research and practical context
Source comparison

BPC-157 Research Hormonal Cycle: Comparison of Follicular vs Luteal Response

Follicular (Days 1–14) Estrogen (50–300 pg/mL) Elevated 30–50% above baseline Low. M2 macrophage dominance Amplified via increased VEGF receptor density Acute injury models, tendon repair studies, maximum angiogenesis protocols Luteal (Days 15–28) Progesterone

This comparison does not assign a generated winner or score.

  • Follicular (Days 1–14)
  • Estrogen (50–300 pg/mL)
  • Elevated 30–50% above baseline
  • Low. M2 macrophage dominance
  • Amplified via increased VEGF receptor density
  • Acute injury models, tendon repair studies, maximum angiogenesis protocols
  • Luteal (Days 15–28)
  • Progesterone (10–20 ng/mL)
  • Reduced 15–25% below peak
  • Elevated. M1 macrophage dominance, sustained TNF-alpha
  • Attenuated due to prolonged inflammatory phase
  • Chronic inflammation models, immune modulation studies, worst-case healing scenarios
  • Ovulatory (Days 12–16)
  • Estrogen peak + LH surge
  • Peak collagen deposition
  • Transitional. Rapid immune cell turnover
  • Variable. Angiogenic surge followed by inflammatory rebound
  • Avoid for outcome consistency. High hormonal volatility
More references

Related material